Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Pinter

Showing results (41-50 of 135) with videos related to

Pageof 14
Sort By:
Dermatology and Therapy|May 24, 2024
Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims DataAndreas Pinter, Ahmed M Soliman, Karina C Manz, et al.
Dermatology and Therapy|July 25, 2023
Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 StudiesLinda Stein Gold, Andreas Pinter, April Armstrong, et al.
The British Journal of Dermatology|May 29, 2026
Repeated switching between biosimilar ABP 654 and reference ustekinumab in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded clinical trial to support interchangeabilityAndrew Blauvelt, Jerry Bagel, Andreas Pinter, et al.
Dermatology and Therapy|November 29, 2023
Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in JapanYayoi Tada, Ahmed M Soliman, Kanako Ishii, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 24, 2023
Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trialNina Magnolo, Thomas Jaenicke, Athanasios Tsianakas, et al.
Vaccines|July 27, 2022
Low Pneumococcal Vaccination among Patients with Psoriasis in Germany: Results from Vac-PsoPhoebe Wellmann, Christian Kromer, Ralf Siemer, et al.
BMC Cancer|October 8, 2016
The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathwaysIgor Hrgovic, Monika Doll, Johannes Kleemann, et al.
The Journal of Dermatology|July 8, 2020
Treatment of acrodermatitis continua of Hallopeau: A case series of 39 patientsChristian Kromer, Emilia Loewe, Marthe-Lisa Schaarschmidt, et al.
Dermatologic Therapy|January 26, 2021
Drug survival in the treatment of generalized pustular psoriasis: A retrospective multicenter studyChristian Kromer, Emilia Loewe, Marthe-Lisa Schaarschmidt, et al.
International Journal of Pharmaceutics|January 12, 2023
How wound environments trigger the release from Rifampicin-loaded liposomesChantal M Wallenwein, Mukul Ashtikar, Götz Hofhaus, et al.
Pageof 14

Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Dermatology and Therapy|May 24, 2024
Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims DataAndreas Pinter, Ahmed M Soliman, Karina C Manz, et al.
Dermatology and Therapy|July 25, 2023
Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 StudiesLinda Stein Gold, Andreas Pinter, April Armstrong, et al.
The British Journal of Dermatology|May 29, 2026
Repeated switching between biosimilar ABP 654 and reference ustekinumab in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded clinical trial to support interchangeabilityAndrew Blauvelt, Jerry Bagel, Andreas Pinter, et al.
Dermatology and Therapy|November 29, 2023
Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in JapanYayoi Tada, Ahmed M Soliman, Kanako Ishii, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 24, 2023
Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trialNina Magnolo, Thomas Jaenicke, Athanasios Tsianakas, et al.
Vaccines|July 27, 2022
Low Pneumococcal Vaccination among Patients with Psoriasis in Germany: Results from Vac-PsoPhoebe Wellmann, Christian Kromer, Ralf Siemer, et al.
BMC Cancer|October 8, 2016
The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathwaysIgor Hrgovic, Monika Doll, Johannes Kleemann, et al.
The Journal of Dermatology|July 8, 2020
Treatment of acrodermatitis continua of Hallopeau: A case series of 39 patientsChristian Kromer, Emilia Loewe, Marthe-Lisa Schaarschmidt, et al.
Dermatologic Therapy|January 26, 2021
Drug survival in the treatment of generalized pustular psoriasis: A retrospective multicenter studyChristian Kromer, Emilia Loewe, Marthe-Lisa Schaarschmidt, et al.
International Journal of Pharmaceutics|January 12, 2023
How wound environments trigger the release from Rifampicin-loaded liposomesChantal M Wallenwein, Mukul Ashtikar, Götz Hofhaus, et al.
Pageof 14